BC-3 and BCBL-1 cells derived from malignant ascites in PEL mice were ex-vivo treated with arsenic, IFN, AZT, or the combinations of arsenic/IFN or AZT/IFN up to 72h. The gene discussed is IFNA1; the disease is cancer.